Want to see FR:EL full AI Analyst Report?
Top Page
EssilorLuxottica SA
(EL)
Select Model
Select Model
Rating:70Outperform
Price Target:
€191.00
▲(20.01% Upside)
Action:Upgraded
Date:10/22/26
The score is primarily supported by strong, stable financial performance (steady growth and high gross margins), but is held back by 2025 margin softening, higher debt, and less-than-best-in-class cash conversion. Technicals are constructive but overbought, and valuation is relatively rich (P/E ~32) with only a moderate dividend yield.
Positive Factors
Vertical integration
EssilorLuxottica controls multiple stages of the eyewear value chain, from product development and manufacturing through distribution and retail. This structure supports cross-selling, improves product availability, captures value across channels, and can reinforce customer reach over the next several quarters.
Negative Factors
2025 margin softening
The 2025 decline in operating and EBITDA margins shows that recent revenue growth has not translated fully into expanding operating profitability. If this pressure persists, it could limit earnings growth, reduce the benefit of scale, and weaken the durability of returns from the business model.
Read all positive and negative factors
Positive Factors
Negative Factors
Vertical integration
EssilorLuxottica controls multiple stages of the eyewear value chain, from product development and manufacturing through distribution and retail. This structure supports cross-selling, improves product availability, captures value across channels, and can reinforce customer reach over the next several quarters.
Read all positive factors
EssilorLuxottica SA (EL) vs. iShares MSCI France ETF (EWQ)
Market Cap
€69.69B
Dividend Yield2.3%
Average Volume (3M)803.41K
Price to Earnings (P/E)32.2
Beta (1Y)1.13
Revenue Growth7.50%
EPS Growth3.48%
CountryFR
Employees213,909
SectorGeneral
Sector StrengthN/A
IndustryMedical - Instruments & Supplies
Share Statistics
EPS (TTM)5.40
Shares Outstanding464,247,560
10 Day Avg. Volume712,081
30 Day Avg. Volume803,411
Financial Highlights & Ratios
PEG Ratio-17.40
Price to Book (P/B)3.19
Price to Sales (P/S)4.35
P/FCF Ratio32.90
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€208.91Price Target Upside31.27% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering12
EPS Forecast (FY)7.24
Revenue Forecast (FY)€30.03B
EssilorLuxottica SA Business Overview & Revenue Model
Company Description
EssilorLuxottica S.A., established in Paris, France, in 1849, is a global enterprise dedicated to the design, production, and distribution of a wide range of ophthalmic products, including corrective lenses, eyewear frames, and sunglasses. The com...
How the Company Makes Money
EssilorLuxottica makes money by selling eyewear products and related optical services through a vertically integrated model that spans design, manufacturing, and distribution.
1) Professional solutions (lenses and optical equipment)
- Prescriptio...
EssilorLuxottica SA Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
74
Positive
Cash Flow
71
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 29.29B | 28.49B | 26.51B | 25.39B | 24.49B | 19.82B |
| Gross Profit | 17.82B | 17.25B | 16.81B | 16.05B | 15.59B | 12.28B |
| EBITDA | 6.76B | 6.54B | 6.55B | 6.21B | 6.10B | 4.71B |
| Net Income | 2.49B | 2.31B | 2.36B | 2.29B | 2.15B | 1.45B |
Balance Sheet | ||||||
| Total Assets | 65.06B | 63.90B | 64.26B | 60.52B | 60.56B | 59.41B |
| Cash, Cash Equivalents and Short-Term Investments | 1.93B | 3.54B | 2.25B | 2.56B | 1.99B | 3.33B |
| Total Debt | 15.32B | 14.40B | 13.22B | 11.66B | 12.20B | 13.02B |
| Total Liabilities | 25.13B | 24.40B | 23.26B | 21.63B | 22.41B | 23.54B |
| Stockholders Equity | 39.22B | 38.89B | 40.38B | 38.24B | 37.45B | 35.06B |
Cash Flow | ||||||
| Free Cash Flow | 3.84B | 3.77B | 3.35B | 3.33B | 3.21B | 3.52B |
| Operating Cash Flow | 5.29B | 5.29B | 4.87B | 4.86B | 4.78B | 4.54B |
| Investing Cash Flow | -2.87B | -2.64B | -3.62B | -1.72B | -3.29B | -8.13B |
| Financing Cash Flow | -3.21B | -971.00M | -1.65B | -2.36B | -2.91B | -1.97B |
EssilorLuxottica SA Technical Analysis
Positive
159.15
Price Trends
151.69
Positive
161.10
Positive
184.73
Negative
Market Momentum
3.99
Negative
76.65
Negative
86.62
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:EL, the sentiment is Positive. The current price of 159.15 is above the 20-day moving average (MA) of 149.63, above the 50-day MA of 151.69, and below the 200-day MA of 184.73, indicating a neutral trend. The MACD of 3.99 indicates Negative momentum. The RSI at 76.65 is Negative, neither overbought nor oversold. The STOCH value of 86.62 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FR:EL.
EssilorLuxottica SA Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | €2.85B | 25.42 | 16.52% | 2.74% | -4.21% | -15.38% | |
70 Outperform | €69.69B | 32.19 | 6.39% | 2.30% | 7.50% | 3.48% | |
64 Neutral | €76.17B | 16.79 | 18.39% | 3.42% | -3.83% | -0.09% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
54 Neutral | €26.53B | -125.00 | -1.46% | 2.40% | -9.23% | -129.21% |
* General Sector Average
FR:EL
EssilorLuxottica SA
177.15
-127.74
-41.90%
FR:CDI
Christian Dior
424.80
-135.23
-24.15%
FR:ITP
Interparfums
34.50
7.42
27.40%
FR:KER
Kering SA
213.50
-126.26
-37.16%
EssilorLuxottica SA Corporate Events
EssilorLuxottica lifts Q3 revenue on strong eyewear, wearable and myopia growth
Oct 20, 2026
EssilorLuxottica reported third-quarter 2026 revenue of €7.49 billion, up 9% year-on-year, or 7.2% at constant exchange rates, building on double-digit growth a year earlier. Revenue for the first nine months rose 6.8% to €22.3 billion...
EssilorLuxottica Sets Investor Call for Q3 2026 Revenue
Oct 9, 2026
EssilorLuxottica SA has scheduled a conference call to discuss its third-quarter 2026 revenue, inviting analysts and investors to join on Tuesday, October 20, 2026, at 6:30 pm CEST. Participants can access the event via pre-registered dial-in cred...
EssilorLuxottica Updates Share Capital and Voting Rights as of September 30, 2026
Oct 8, 2026
EssilorLuxottica reported that as of September 30, 2026, it had 464,247,548 shares outstanding, corresponding to 458,372,353 real voting rights once treasury shares are excluded. The theoretical number of voting rights matches the total shares out...
EssilorLuxottica Buys Back 74,083 Shares Under Ongoing Share Repurchase Plan
Sep 28, 2026
EssilorLuxottica SA disclosed that it repurchased 74,083 of its own shares on September 21, 2026, under a buyback authorization granted by shareholders at the April 2026 general meeting. The purchases were executed across multiple trading venues a...
EssilorLuxottica and Meta widen AI glasses push with new Ray-Ban lineup and global rollout
Sep 24, 2026
EssilorLuxottica and Meta Platforms unveiled a major expansion of their AI glasses portfolio at Meta Connect, introducing Ray-Ban Meta Audio, a camera-free line of ultra-light audio AI glasses, and Ray-Ban Meta Gen 3 with slimmer design, longer ba...
EssilorLuxottica Steps Up Capital Management With Fresh Share Buybacks
Sep 21, 2026
EssilorLuxottica SA has disclosed a new tranche of share buybacks carried out on 18 September 2026 under an authorization granted by its General Meeting held on 28 April 2026. The group repurchased a total of 287,000 shares across several European...
EssilorLuxottica Details Share Capital and Voting Rights Structure as of August 2026
Sep 10, 2026
EssilorLuxottica reported that, as of August 31, 2026, its share capital is composed of 464,247,548 shares, corresponding to 459,153,735 actual voting rights and 464,247,548 theoretical voting rights. The figures reflect the exclusion of treasury ...
EssilorLuxottica Board Reaffirms Confidence in Leadership and Strategy
Sep 9, 2026
EssilorLuxottica’s Board of Directors has unanimously reaffirmed its full confidence in Chairman and CEO Francesco Milleri, Deputy CEO Paul du Saillant and the wider management team, following recent press articles and public statements. The...
EssilorLuxottica Buys Back 424,681 Shares Under Shareholder Authorization
Sep 7, 2026
EssilorLuxottica has disclosed recent share buyback activity carried out under an authorization granted by shareholders at the April 28, 2026 annual meeting. Between August 31 and September 3, the company repurchased a total of 424,681 shares acro...
EssilorLuxottica Updates Share Capital and Voting Rights Structure as of July 31, 2026
Sep 3, 2026
EssilorLuxottica reported that as of July 31, 2026 its share capital is composed of 464,247,548 shares, corresponding to 464,247,548 theoretical voting rights and 459,591,833 actual voting rights net of treasury shares. The company also highlighte...
EssilorLuxottica Details €158.97-Average Buyback of 300,335 Shares
Aug 31, 2026
EssilorLuxottica SA has disclosed recent transactions in its own shares under a buyback program authorized by shareholders at the April 28, 2026 annual meeting. Between August 25 and August 27, 2026, the group repurchased a total of 300,335 shares...
EssilorLuxottica Launches Share Buyback Program to Signal Confidence
Aug 28, 2026
EssilorLuxottica has launched a new share buyback program, authorizing an investment services provider to repurchase up to 5 million of its shares on the market starting August 28, 2026, subject to market conditions. The move, carried out under a ...
EssilorLuxottica Discloses August Share Buyback Activity
Aug 26, 2026
EssilorLuxottica has disclosed a series of share buyback transactions conducted between August 17 and August 21, 2026, under an authorization granted by shareholders at the April 28, 2026 Annual Meeting. Over this period, the group repurchased a t...
EssilorLuxottica Publishes 2026 Interim Financial Report After Board Approval
Jul 29, 2026
EssilorLuxottica has released its 2026 Interim Financial Report following Board approval of the condensed consolidated interim financial statements for the six months ended June 30, 2026. The publication provides investors and stakeholders with up...
EssilorLuxottica Delivers Strong H1 Growth and Bets on Intelligent Optical Systems
Jul 28, 2026
EssilorLuxottica reported a strong first half of 2026, with revenue up 9.7% at constant exchange rates and second-quarter growth of 8.7%, supported by an 8.0% rise in comparable-store retail sales. All major regions contributed, with North America...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.